Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Glioma SOX2 expression decreased after adjuvant therapy

Fig. 3

Expression of SOX2 in a representative patient with primary and paired recurrent gliomas. The patient was diagnosed as glioblastoma with SOX2 3+ after first operation in 2013, the histological diagnosis was stilll glioblastoma when recurrence in 2014, but the expression of SOX2 was negative (0+)

Back to article page